Investigative Report on Chinese Tigercycline Markets, 2016-2020 and 2021-2025: An Intravenously Administered Broad-Spectrum Glycylcyclic Peptide Antibiotic
DUBLIN, March 10, 2022–(BUSINESS WIRE)–The “China Tigercycline Market Investigation Report 2021-2025” report has been added…